Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Iovance Biorapeutics
7 Analysts Have This to Say About Iovance Biotherapeutics
Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter:
Benzinga ·
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
Nasdaq
22,848 stories
NYSE
19,912 stories
Barclays
1,850 stories
Wells Fargo
1,151 stories
UBS
1,082 stories
JP Morgan
756 stories
Advanced Micro Devices
573 stories
Oppenheimer
409 stories
Caterpillar
326 stories
Paramount Global
304 stories
Amgen
194 stories
BMO Capital
132 stories
Gilead Sciences
125 stories
Aon
114 stories
Guggenheim
114 stories
Texas Roadhouse
107 stories
Pure Storage
63 stories
DaVita
60 stories
Keurig Dr Pepper
58 stories
Cedar Fair
29 stories
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
